S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

DXF Dunxin Financial Holdings Ltd

0.0884

0.00 (0.00%)

Nov 14 2024 - Closed

Delayed by 15 minutes

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

nullnullnullnullnull

Dunxin Financial (AMEX:DXF)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Dunxin Financial Charts.

Dunxin Financial (AMEX:DXF)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Dunxin Financial Charts.

Dunxin Financial Holdings Ltd News

Dunxin Financial Holdings Limited Announces $162,500 Convertible Promissory Note Private Placement
Tuesday 29 October 2024 (3 weeks ago) • PR Newswire (US)

Dunxin Financial Holdings Limited Announces Planned Name Change to Eason Technology Limited and 2024 Annual General Meeting of Shareholders
Tuesday 1 October 2024 (2 months ago) • PR Newswire (US)

Dunxin Financial Holdings Limited Announces Management Changes
Wednesday 25 September 2024 (2 months ago) • PR Newswire (US)

Dunxin Financial Holdings Limited Announces NYSE American Notice of Delisting
Monday 23 September 2024 (2 months ago) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 23 September 2024 (2 months ago) • Edgar (US Regulatory)

Dunxin Financial Holdings Limited Files Annual Report on Form 20-F for Fiscal Year 2023
Friday 12 July 2024 (4 months ago) • PR Newswire (US)

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Thursday 16 May 2024 (6 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 13 May 2024 (6 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 6 December 2023 (11 months ago) • Edgar (US Regulatory)

More Dunxin Financial Holdings Ltd News Articles

Fannie Mae (QB)

North Bay Resources (PK)

Northwest Biotherapeutics (QB)

Anavex Life Sciences

Digital Brand Media and ... (PK)

Elite Pharmaceuticals (QB)

Intergrated Cannabis Sol... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions